EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications

Krushnaa Sankhe iD, Daniella Vellone, Dylan X Guan, Byron Creese, Zahinoor Ismail, Sanjeev Kumar, Krista L Lanctôt, Moyra E Mortby, Fabricio Ferreira de Oliveira, Lindsey Sinclair, Jennifer Gatchel, Catherine E Munro iD

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70510 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 02.11.2026. Verfasst von Krushnaa Sankhe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sunnybrook Research Institute Toronto Ontario Canada. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of Alzheimer's disease (AD) research has seen major advances in understanding manifestations of AD‐related neuropsychiatric symptoms (NPS), including recent addition of NPS to the 2024 National Institute of Aging–Alzheimer's Association (NIA‐AA) clinical staging framework. This focused review highlights key publications (49 in 2024; 28 in 2025) indexed in MEDLINE examining AD‐related NPS, in alignment with the Scale for the Assessment of Narrative Review Articles guidelines. Data were thematically organized across NIA‐AA clinical stages, with emphasis on measurement, diagnosis, and biomarker‐cognition correlates of AD‐related NPS. Together, these findings can inform future research and clinical practice through enhanced understanding of AD‐related NPS and their relationships with pathology and clinical outcomes. Finally, three key priorities were identified for future research: (1) incorporating sex/gender and ethnocultural diversity; (2) integrating NPS assessment with cognitive, fluid, and neuroimaging biomarkers; and (3) including perspectives of individuals with lived experience to support personalized NPS management.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerscognitioninterventionsneuropsychiatric symptoms

Autor:innen und Institutionen

  • Sunnybrook Research Institute Toronto Ontario Canada.
  • Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada.
  • Faculty of Graduate Studies University of Calgary Calgary Alberta Canada.
  • Hotchkiss Brain Institute Cumming School of Medicine University of Calgary Calgary Alberta Canada.
  • Department of Psychology Brunel University of London Uxbridge, London UK.
  • Department of Psychiatry Cumming School of Medicine University of Calgary Calgary Alberta Canada.

ORCID-Profile: Krushnaa Sankhe, Catherine E Munro

Zitieren

APA

Sankhe, K., Vellone, D., Guan, D. X., Creese, B., Ismail, Z., Kumar, S., Lanctôt, K. L., Mortby, M. E., de Oliveira, F. F., Sinclair, L., Gatchel, J., & Munro, C. E. (2026). Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(4). https://doi.org/10.1002/dad2.70510

Vancouver

Sankhe K, Vellone D, Guan DX, Creese B, Ismail Z, Kumar S, et al. Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(4). doi:10.1002/dad2.70510

BibTeX
@article{Sankhe2026,
  author = {Sankhe, Krushnaa and Vellone, Daniella and Guan, Dylan X and Creese, Byron and Ismail, Zahinoor and Kumar, Sanjeev and Lanctôt, Krista L and Mortby, Moyra E and de Oliveira, Fabricio Ferreira and Sinclair, Lindsey and Gatchel, Jennifer and Munro, Catherine E},
  title = {Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1002/dad2.70510}
}
Kostenlos starten →